NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Genetics & Environmental Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genetics & Environmental Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiogenesis



New angiogenesis study findings have been reported by scientists at University of Paris



November 22nd, 2007

Scientists discuss in 'Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis' new findings in angiogenesis. According to recent research from France, "The formation of new blood vessels, uncontrolled cell expansions and invasions are the common feature of cancer, neovascular inflammatory and ocular diseases, such as age-related macular degeneration (AMD). Short interfering RNA (siRNA) and short-hairpin RNA (shRNA) have recently helped extend our understanding of the mechanisms regulating angiogenesis and tumor developments."

"Moreover, the early success of these tools has reinforced the therapeutic hopes of preventing endogenous or exogenous...


Source: Genetics & Environmental Business Week (2007-11-22)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login